VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Araris Biotech

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

  • Biotech & therapeutics
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Araris Biotech was a spin-off from the PSI / ETH Zurich developing next generation antibody-drug conjugates for the treatment of different cancers. In March 2025, Araris was acquired by Taiho Pharmaceutical for up to $1,140 million.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy